LMBA02 Protocol for Patients With a Burkitt Lymphoma
Burkitt Lymphoma
About this trial
This is an interventional treatment trial for Burkitt Lymphoma
Eligibility Criteria
Inclusion Criteria: Age : 18 years or older Histologically or cytologically proven Burkitt lymphoma according to the WHO classification WHO performance < 3 Informed consent Exclusion Criteria: Known HIV positive infection Positive serology for HCV and HBV (except after vaccination) Patients previously treated for lymphoma cardiac disease that contradict anthracycline chemotherapy Psychological or psychiatric condition who contradict steroids therapy Patients with serious renal failure unrelated to the lymphoma (serum creatinin level higher than 150 mmole/L) Cirrhosis or severe hepatic failure unrelated to the lymphoma Previous malignant disease except basal cell skin carcinoma or in situ uterine cervix carcinoma Any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule Primary organ transplant or other immunosuppressive conditions Pregnancy
Sites / Locations
- Institut Gustave RoussyRecruiting